Tragedies in Clinical Trials - A History Wrapped Up
Journal Title: International Journal of Clinical Pharmacology & Toxicology(IJCPT) - Year 2015, Vol 4, Issue 3
Abstract
Today foremost emphasis is being given to the protection of patient’s safety and ethics during the conduct of clinical trials. Serious considerations by regulatory authorities are taken to safeguard the patient’s right, safety and wellbeing involved in a clinical trial. In addition considerations like International Conference on Harmonization (ICH) guidelines, Investigational New Drug (IND) application, New Drug Application (NDA), Post Marketing Surveillance (PMS) and Periodic Benefit-Risk Evaluation Report (PBRER) formerly known as Periodic Safety Update Report (PSUR) submissions to different regulatory authorities has also been framed to strengthen ethics and patient’s safety. However modern clinical trials have evolved through serious consequences and tragedies like Thalidomide Tragedy, Sulfanilamide Disaster, Clioquinolol Tragedy, etc. associated with high morbidity and mortality. Potential reasons behind these tragedies include unethical clinical practices, inadequate preclinical safety and efficacy data, non-scientific conduct, lack of attentiveness for patient care, misinterpretation of safety data, lack of pharmaco-vigilance, slow withdrawal of drug from market etc. Hence toiling efforts have been made and should be made in investigating lacunas in national as well as international systems that encourage launch of such spurious drugs that needed withdrawals after 10-20 years of public use. This manuscript intends to collect and present data on tragic clinical trials, highlight the tragedies that occurred during the dark era of clinical trials and enumerate various corrective actions taken in response to the lessons learnt during those clinical trials.
Authors and Affiliations
Parveen Bansal
Keywords
Related Articles
- EP ID EP201748
- DOI 10.19070/2167-910X-1500029
- Views 70
- Downloads 0
Protective Effect of Montelukast against Cadmium Induced Pituitary Gland Toxicity
Cadmium (Cd) is a common environmental hazardous heavy metal. The standard treatment of heavy metal intoxication;chelators may have a minor role in Cd toxicity. Montelukast (ML) is an anti-inflammatory drug that is used...
Assessment of Fatigue and Its Associated Factors in Breast Cancer Patients Under Treatment
Fatigue is a common distressing problem in most beast cancer patients. It may be caused by the disease, the complications of the disease and its treatments. This study aimed to assess fatigue and associated factors in br...
Antioxidant Effects of Vitamin E in Diabetes Mellitus Type 1
In diabetes mellitus atherosclerosis is precocious, accelerated, and extensive, having influence to a large extent the secondary dislipoproteinemia to the hyper-glucemia, the lipoprotein’s glucosilation produce changes i...
Degradation Pathway for Rilpinavir Hydrochloride by Validated Stability Indicating UP-LC Method
Degradation pathway for Rilpivirine Hydrochoride is established as per ICH recommendations by validated and stability indicating reverse phase liquid chromatographic method. Rilpivirine Hydrochoride is subjected to stres...
Pharmacological and Toxicological Effects of Chemotherapy on Cancer Patients in This Era and The Role of Open Access Journals in This Matter
Open access journal consider as a constructive way in exchange the knowledge related with chemotherapy pharmacological and toxicological effect in cancer treatment. Therefore, Open Access Journals play as a very supporti...